South African guideline for the diagnosis, management and prevention of acute viral bronchiolitis in children

South African Medical Journal

Volumn 100, Issue 5, 2010, Pages 320-325

  Green, Robin J ^a   Zar, Heather J ^a   Jeena, Prakash M ^a   Madhi, Shabir A ^a   Lewis, Humphrey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; MONTELUKAST; PALIVIZUMAB; PLACEBO; PREDNISOLONE; RIBAVIRIN; SALBUTAMOL; SODIUM CHLORIDE;

ARTERIAL OXYGEN SATURATION; BACTEREMIA; BREATHING EXERCISE; BRONCHIOLITIS; CHILD; CHILD CARE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG INDICATION; GENOTYPE; HOSPITAL HYGIENE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MIXED INFECTION; NONHUMAN; OXYGEN THERAPY; PATIENT EDUCATION; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RHINOVIRUS; RISK FACTOR; SEASONAL VARIATION; SOUTH AFRICA; VIRAL BRONCHIOLITIS; WHEEZING;

EID: 77952528639     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4016     Document Type: Review

References (46)

1. Wohl MEB. Bronchiolitis. In: Chernick V, Boat TF, Wilmot RW, Bush A, eds. Kendig's Disorders of the Respiratory Tract in Children. Philadelphia: Saunders, Elsevier, 2006: 423-432.
2. Matti K, Kotaniemi-Syrjänen A, Waris M, Vainionpää R, Reijonen TM. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 2004; 23: 995-999.
3. Madhi SA, Venter M, Alexandra R, et al. Respiratory syncytial virus associated illness in high- risk children and national characterisation of the circulating virus genotype in South Africa. J Clin Virol 2003; 27: 180-189.
4. Venter M, Collinson M, Schoub BD. Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes responsible for different disease manifestations. J Med Virol 2002; 68: 452-461.
5. Hall CB, Walsh EE, Schnabel KC, et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: Associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990; 162: 1283-1290.
6. King JC, Burke AR, Clemens JD, et al. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. Pediatr Infect Dis J 1993; 12: 733-739.
7. Moodley T, Masekela R, Kitchin O, Risenga S, Green RJ. Acute viral bronchiolitis. Aetiology and treatment implications in a population that may be HIV co-infected. S Afr J Epidemiol Infect 2010 (in press).
8. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282: 1440-1446.
9. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 2001; 183: 16-22.
10. Morrow BM, Hatherill M, Smuts HE, Yeats J, Pitcher R, Argent AC. Clinical course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus. J Paediatr Child Health 2006; 42: 174-178.
11. Weber MW, Milligan P, Sanneh M, et al. An epidemiological study of RSV infection in the Gambia. Bull World Health Organ 2002; 80(7): 562-568.
12. Bloomfield P, Dalton D, Karleka A, Kesson A, Duncan G, Isaacs D. Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch Dis Child 2004; 89: 363-367.
13. Kyneber M, van Oud-Alblas H, van Vliet M, Uiterwaal C, Kimpen J, van Vught A. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med 2005; 31: 680-685.
14. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HKF. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006; 61: 611-615.
15. Madhi SA, Klugman KP, The Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nature Med 2004; 10: 811-813.
16. Spurling GKP, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Library 2007; 1: CD005189.
17. Madhi SA, Venter M, Madhi A, Petersen K, Klugman KP. Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 2001; 20: 164-170.
18. Field CMB, Connolly JH, Slattery CM, Turkington EE. Antibiotic treatment of epidemic bronchiolitis - a double-blind trial. BMJ 1966; 1: 83-85.
19. Friis B, Andersen P, Brenøe E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984; 59: 1038-1045.
20. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med 1996; 150: 1166-1172.
21. Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2006; 3: CD001262.
22. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Datbase Syst Rev 2004; 1: CD003123.
23. Henry RL, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983; 58: 925-926.
24. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008; 4: CD006458.
25. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis: A meta-analysis. Pediatrics 2000; 105(4): 1-6.
26. Roosevelt G, Sheenan K, Grupp-Phelan J, et al. Dexamethasone in bronchiolitis: a controlled trial. Lancet 1996; 348: 292-295.
27. Kimpen JLL. Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. Respir Res 2002; 3: Suppl 1, S40-S45.
28. Jartti T, Pasi L, Timo V, et al. Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or RSV. Pediatr Infect Dis J 2006; 25: 482-488.
29. Teereatakulpisarn J, Limwattananon C, Tanupattarachai S, Limwattananon S, Teereatakulpisarn S, Kosalaraksa P. Efficacy of dexamethasone injection for acute bronchiolitis in hospitalized children: a randomized, double-blind, placebo-controlled trial. Pediatr Pulmonol 2007; 42: 433-439.
30. Corneli HM, Zorc JJ, Mahajan P, et al. A multicentre, randomized, controlled trial of dexamthasone for bronchiolitis. N Engl J Med 2007; 357: 331-339.
31. Cade A, Brownlee KG, Conway SP, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncitial viral bronchiolitis. Arch Dis Child 2000; 82: 126-130.
32. Wong JY, Moon S, Beardsmore C, O'Callaghan C, Simpson H. No objective benefits from steroids inhaled via a spacer in infants recovering from bronchiolitis. Eur Respir J 2000; 15: 388-394.
33. Fox GF, Everard ML, Marsh MJ, Milner AD. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child 1999; 80: 343-347.
34. Blom D, Ermers M, Bont L, van Aalderen WM, van Woensel JB. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007; 1: CD004881.
35. Amirav I, Luder AS, Kruger N, et al. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics 2008; 122: 1249-1255.
36. Bisgaard H, Flores-Nunez A, Goh A, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 2006; 178: 854-860.
37. Law BJ, Wang EEL, MacDonald N, et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database. Pediatrics 1997; 99: e7.
38. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2005; 2: CD004873.
39. Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis- associated deaths among infants in the United States. Pediatr Infect Dis J 2003; 22: 483-489.
40. Gavin R, Anderson B, Percival T. Management of severe bronchiolitis: indications for ventilator support. NZ Med J 1996; 109: 137-139.
41. Bush A, Thomson AH. Acute bronchiolitis. BMJ 2007; 335: 1037-1041.
42. Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in children. A national clinical guideline. 2006. www.sign.ac.uk (accessed 28 November 2009).
43. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003; 143: 532-540.
44. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from the respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531-537.
45. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171: 137-141.
46. Motala C, Green RJ, Kling S, Manjra A, Potter PC, Zar HJ, For the South African Childhood Asthma Working Group (SACAWG). Guideline for the management of chronic asthma in children - 2009 update. S Afr Med J 2009; 99: 898-912.